COMMUNIQUÉS West-GlobeNewswire
-
Portsmouth Square, Inc. Reports First Quarter Fiscal 2027 Results; Pedestrian Bridge Removal Complete and Hotel Reopened After City-Mandated Closure
17/11/2026 -
Erasca Enters into Clinical Collaboration with Bristol Myers Squibb to Evaluate ERAS-0015 in Clinical Study with Navlimetostat
18/11/2026 -
Non-Surgical Hair Restoration in NYC: Park Avenue Practice Opens Dedicated GLP-1 Hair Loss Assessments for January, With Procedure Decided Only After Blood Work
17/11/2026 -
COP31 : l’EAACI appelle à intégrer les allergies et la santé respiratoire dans les politiques de lutte contre le changement climatique
17/11/2026 -
MATTER Honors Companies Turning Employee Activation Into Community Impact
17/11/2026 -
Priavoid Announces Topline Phase 2 Data for Oral All-D-Peptide PRI-002 in Alzheimer’s Disease at CTAD 2026
17/11/2026 -
Dazed, Inc. Reports 72.5% Gross Margin and 121% Royalty Growth as Texas Lawmakers File Adult-Use Cannabis Bills in Home Market
17/11/2026 -
Newly Launched CuraeChoice Platform Unlocks Healthcare Pricing Visibility for Nearly 370,000 Employers by Tax ID Alone
17/11/2026 -
Terumo Neuro Announces Publication of RESTORE Registry Results in the Journal of NeuroInterventional Surgery
17/11/2026 -
Acoramidis Was Associated with Lower Risk of Worsening Heart Failure Versus Tafamidis in Real-World Study and Reduced Heart Failure Events Within One Month in ATTRibute-CM
17/11/2026 -
Weight Watchers Announces Discounted Prepayment Solicitation to Utilize Up to $10 Million to Reduce Term Loan Debt
17/11/2026 -
Davion Healthcare Plc Provides Shareholders with Guidance on Direct Registration and Confirmation of Share Ownership
17/11/2026 -
Nine-month interim report (Q3) 2026 (unaudited)
17/11/2026 -
Medicenna Therapeutics Reports Second Quarter Fiscal 2027 Financial Results and Provides Corporate Update
17/11/2026 -
Firefly Neuroscience Reports 373% Year-Over-Year Increase in U18 ADHD Evoke™ Scans as Commercial Expansion Accelerates
17/11/2026 -
Senti Bio Announces Reverse Stock Split
17/11/2026 -
Nasus Pharma Presents Data at ACAAI 2026 Demonstrating NS002 Reached the Therapeutic Epinephrine Threshold Faster Than an Autoinjector After Repeat Dosing and Under Severe Nasal Congestion
17/11/2026 -
MIRA Pharmaceuticals Reports New MIRA-55 Selectivity Findings Supporting a Differentiated Non-Opioid Approach to Pain
17/11/2026 -
BetterLife Pharma Announces Stock Option Grant
17/11/2026
Pages